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tenascin-c inactivation impacts 
lung structure and function beyond 
lung development
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Johannes c. Schittny  4 & tiziana p. cremona4
tenascin-c (tnc) is an extracellular matrix protein expressed at high levels during lung organogenesis. 
Later, tnc is only transiently de novo expressed to orchestrate tissue repair in pathological situations. 
We previously showed that TNC inactivation affects lung development and thus evaluated here the 
implications on lung function in newborn/adult mice. Respiratory function parameters were measured 
in anesthetized and mechanically ventilated wild-type (WT) and TNC-deficient mice at 5 (P5) and 90 
(P90) days of age under basal conditions, as well as following high tidal volume (HTV) ventilation. At P5, 
TNC-deficient mice showed an increased static compliance (Cst) and inspiratory capacity (IC) relative to 
WT at baseline and throughout HTV. At P90, however, Cst and IC were only elevated at baseline. Control 
non-ventilated newborn and adult TNC-deficient mice showed similar lung morphology, but less alpha 
smooth muscle actin (α-SMA) around small airways. SMA + cells were decreased by 50% in adult TNC-
deficient lungs and collagen layer thickened around small airways. Increased surfactant protein C (SP-
c) and altered tGfβ and TLR4 signaling pathways were also detected. Thus, TNC inactivation-related 
defects during organogenesis led to persisting functional impairment in adulthood. this might be of 
interest in the context of pulmonary diseases with thickened airway smooth muscle layer or ventilation 
heterogeneity, like asthma and COPD.
Tenascin-C (TNC) is a large hexameric protein and the founding member of the tenascin family of extracellular 
matrix (ECM) proteins1,2. TNC binds to cell surface receptors, ECM proteins or, more recently discovered, soluble 
factors or pathogens to regulate cell adhesion, migration, proliferation and differentiation1,3–5. TNC is a complex 
protein with post-transcriptional (alternative splicing) and post-translational (glycosylation, citrullination, prote-
olytic processing) regulations giving rise to numerous isoforms having sometimes opposite effects on cell behav-
ior, moreover in a cell-dependent manner5,6. Its expression is highly regulated in time and space, with a strong 
expression during specific morphogenetic events throughout embryogenesis and organogenesis especially in the 
lung1,2,5,7. In the growing lung, it is expressed at the epithelial-mesenchymal interface at the tips of developing 
airways during branching morphogenesis, and throughout lung mesenchyme during alveolarization8,9. In adult 
tissues, there is very little or no TNC expression, except in small foci of tissues subjected to high tensile stress or in 
certain stem cell niches1,8. Otherwise, TNC is de novo re-expressed only transiently in pathological situations like 
inflammation or tissue damage, or permanently in diseases like cancer or rheumatoid arthritis1,10,11.
TNC is highly expressed in many chronic lung diseases like chronic obstructive pulmonary disease (COPD), 
bronchopulmonary dysplasia (BPD), idiopathic pulmonary fibrosis (IPF), respiratory distress syndrome (RDS) 
and asthma, where it is even considered as a marker of severity12–16. In the 1990’s, two research groups generated 
TNC-deficient mice: Saga et al.17 and Forsberg et al.18. Both animal models showed that TNC inactivation was 
not lethal and did not induce any reproductive alteration. Studies in TNC knockout (KO) mice showed that lung 
disease phenotype was largely reduced in the absence of TNC in acute lung injury19, in selective epithelial lung 
injury20 or in ovalbumin-induced asthma21.
In lung development, we previously showed that TNC inactivation induced a defect in branching morpho-
genesis (early lung development)22 and alveolarization (late lung development)23. In early lung development, 
absence of TNC reduced the number of branches of the developing airways, and in late development, it delayed 
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alveolarization. However, if newborn TNC KO lungs were shown to have an altered morphometry, adult lungs of 
TNC KO mice appeared morphometrically identical to WT ones at three months of age22,23.
In this study, we sought to evaluate the functional consequences of TNC inactivation in the lung, and the 
potential long-term repercussions of damage observed during lung development. Our results showed that alter-
ations of the respiratory function not only exist at newborn age, but also persist in adulthood. This is associated 
with modifications of structural proteins like α-SMA or collagen, and an altered expression of transforming 
growth factor β (TGFβ) and Toll-like receptor 4 (TLR4) signaling pathways intermediates. Together, these results 
indicate that even if TNC is no more expressed in adult tissues, its inactivation in early stages persistently affects 
the lung in adults, in a way that could be relevant for pulmonary diseases with increased airway smooth muscle 
layer.
Results
Long tnc isoforms are only expressed in newborn developing lungs. TNC isoforms differ in 
the number and the composition of alternatively spliced fibronectin-like type III (fnIII) domains present in the 
mature mRNA, ranging from 0 to 6 fnIII domains in the mouse (Fig. 1a). Primers lining the alternatively spliced 
region were used to amplify TNC mRNAs by RT-qPCR. In newborns, small and large size PCR fragments were 
found, with 1–6 alternatively spliced fnIII domains (Fig. 1b,c). In contrast, in adults, only small fragments with 
0–1 fnIII domains were observed (Fig. 1d,e). At the protein level, TNC was highly expressed in lung parenchyma 
in newborn lungs (Fig. 2a,b,e); however, in adult lungs, TNC protein expression was undetectable by immunohis-
tochemistry (Fig. 2c,d) or Western blot (Fig. 2f).
Basal pulmonary function is persistently altered in tnc Ko mice. To determine the impact of TNC 
inactivation on the respiratory function, we measured basal respiratory function in anesthetized and mechan-
ically ventilated newborn (P5) and adult (P90) WT and TNC KO mice (Fig. 3). At P5 and at P90, there were 
obvious changes in the shape of the PV curves between TNC KO and WT animals (Fig. 3e,j). Relative to WT, 
static compliance (Cst), an index of the distensibility of the respiratory system, and parameter A, an estimate 
of the inspiratory capacity (IC), were both significantly higher in TNC KO animals under basal conditions 
(Fig. 3a,f,b,g). There was no statistical difference in parameter K, a measure of the overall curvature of deflation 
limb of the PV curves, nor in hysteresis (area), estimating atelectasis existing before the PV loop (Fig. 3c,h,d,i). 
We also calculated the work of breathing (WOB), which is an indicator of increased effort to breathe, from the 
Figure 1. TNC isoforms in newborn and adult WT mice. Lung total RNA (lanes 1–2; two WT samples) was 
amplified by RT-qPCR with two sets of primers surrounding the alternatively spliced fnIII domains of TNC 
gene: primers 5f-6r, which immediately border the alternatively spliced region, and primers 5s-6as, located 
at the 5’ end of fnIII domain 5 and at 3’ end of fnIII domain 6. Panel a: drawing of the mouse TNC gene, with 
the localization of the primers pairs. Panel b,c: RT-qPCR from newborn lungs; Panel d,e: RT-qPCR from adult 
lungs; Panel b,d: RT-qPCR with primers 5s-6as; Panel c,e: RT-qCR with primers 5f-6r. Each fnIII domain is 273 
nucleotides long. RT-qPCRs are run on 2% agarose gels with 100 bp DNA ladder as size marker. Isoforms are 
indicated by arrows on the right side of the gel.
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area under the inflation limb of the PV curves (Fig. 3e,j). WOB at time 0 was similar in the newborn TNC KO 
and WT mice at P5 (1.84 ± 0.16 vs 1.86 ± 0.16 J/L, respectively) as well as in the adult mice at P90 (1.72 ± 0.13 
vs 1.58 ± 0.31 J/L, respectively, for TNC KO and WT animals). Since TNC expression was observed in tissues 
exposed to tension, we then investigated TNC KO and WT mice under a mechanical stress induced by a high 
tidal volume (HTV) profile. Newborn and adult mice were both subjected during one hour to a HTV protocol 
and respiratory function parameters were recovered every 15 minutes (Fig. 4). Following HTV, differences in the 
shape of the PV curves between WT and TNC KO animals were only apparent in the newborn mice (Fig. 4e,j). 
Like what was observed under baseline conditions, static compliance and IC both remained elevated in the TNC 
KO newborn mice relative to WT during the whole HTV ventilation challenge (Fig. 4a,b). Parameter K was iden-
tical in both genotypes during the whole experiment (Fig. 4c) and hysteresis tended to be higher in the newborn 
TNC KO animals throughout the whole HTV challenge (p ≤ 0.1 at each time point; statistically significant only at 
the end of the ventilation) (Fig. 4d). In the adult mice, similar PV curves were obtained in the TNC KO and WT 
mice following 60 minutes of HTV (Fig. 4j), and, consistently, both genotypes showed superimposed values for 
all related parameters (Fig. 4f–i). In order to test the hypothesis of a change in surfactant production, surfactant 
protein B and C (SP-B and SP-C) protein expression were evaluated by Western blot. SP-C, but not SP-B, protein 
expression was slightly increased in adult TNC KO lung samples (Fig. 4k–m).
collagen staining is increased around small airways in adult tnc Ko lungs. To evaluate whether 
certain structures or structural proteins were modified concurrently, histological stainings were performed on P5 
lung sections. Hematoxylin-eosin (H&E) staining of lung sections indicated a similar morphology in both TNC 
KO and WT newborn lungs (Fig. 5a,b). However, when comparing ventilated animals to controls of the same 
age, we observed a strong thickening and a cellular infiltration of the inter-saccular septa in ventilated animals 
(both WT and TNC KO) suggesting an inflammatory reaction in response to the HTV ventilation (Fig. 5c,d). 
Resorcin-fuchsin staining of elastin fibers did not highlight any difference in elastin distribution between TNC 
KO and WT lungs (Fig. 5e,f). Collagen fibers staining with Masson trichrome showed a faint collagen staining 
which was not different in TNC KO compared to WT lung (Fig. 5g,h).
The same histological stainings as for newborn (P5) lungs were performed on P90 lung sections. We did not 
find any morphological differences between TNC KO and WT lungs with hematoxylin-eosin staining (Fig. 6a,b). 
Elastin staining and protein expression were similar in both TNC KO and WT lungs (Fig. 6c,d,j,k). However, 
Figure 2. TNC protein expression in lungs of newborn and adult TNC KO and WT mice. Panel a-d: 
Representative images from lung sections of TNC KO and WT animals, immunostained with anti-TNC 
antibody (dark grey). Sections were counter-stained with Nuclear Red. (a) WT P5; (b) TNC KO P5; (c) WT 
P90; (d) TNC KO P90. Magnification:40×. N = 4–7 animals for P5, and n = 6 animals for P90. Panel e,f: 
Representative results of TNC protein detection in whole lung lysates from TNC KO and WT animals by 
Western blots. Cropped blots are displayed. Full length blots are presented in Supplementary Figure S2. (e) 
newborns lung samples; (f) adult lung samples, P5 WT sample as a positive control.
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Masson trichrome staining revealed a thicker layer of collagen around small airways in TNC KO animals (Fig. 6e–
h). Image analysis confirmed a 2.4 ± 0.5 fold increase in collagen area per length of basement membrane in TNC 
KO lungs (Fig. 6i).
Alpha smooth muscle actin (α-SMA) is decreased in newborn and adult TNC KO 
lungs. Alpha-smooth muscle actin (α-SMA) protein immunostaining at P5 was weaker in TNC KO lungs, 
especially around small airways and at the tips of the developing septa, but also to a lesser degree around large 
airways and arterial blood vessels (Fig. 7a,b). Nevertheless, whole lung α-SMA protein expression was identical 
in both genotypes (Fig. 7g,i). At P90, α-SMA immunostaining was largely weaker in TNC KO lung around small 
airways and to a lesser extend around larger airways and arterial blood vessels (Fig. 7c–f). Moreover, flow cytom-
etry experiments showed a 50% decrease (p = 0.087) in the percentage of SMA + cells in TNC KO lungs (Fig. 7o), 
with a similar percentage of decrease in both genotypes, in SMA + desmin+ cells (smooth muscle cells) and 
SMA + vimentin+ cells (myofibroblasts) (Fig. 7p,q). Interestingly, the percentage of proliferating cells (ki67 +) of 
both populations was even lower in TNC KO samples, compared to the same population in WT (Fig. 7r,s). Whole 
lung α-SMA protein expression was, however, overall slightly increased in TNC KO animals (Fig. 7h,j). In order 
to test other major proteins of smooth muscle actin fibers, whole lung protein expression of smooth muscle myo-
sin heavy chain (MYH11) and phosphorylated form of smooth muscle myosin light chain (PMLC2) was checked 
in parallel. Expression of both proteins were the same in both adult TNC KO and WT animals (Fig. 7k–n).
tnc-related tGfβ and TLR4 pathways are upregulated in adult TNC KO lungs. Expression of 
transforming growth factor beta (TGFβ) pathway components was evaluated by RT-qPCR in P90 lungs to see if 
the principal TNC-related pathway was affected in parallel to lung function in TNC KO lungs. TGFβ1 and TGFβ 
receptor 1 (TGFβR1), -R2 and -R3 mRNA expression were largely increased in TNC KO lungs, whereas TGFβ2 
and −3 were unchanged (Fig. 8a). Smad2 and Smad3 mRNAs were also largely increased in TNC KO lungs, but 
the expression of their phosphorylated protein was only slightly increased, as seen by Western blot (Fig. 8b–e). 
TNC was also shown to be a ligand for Toll-like receptor 4 (TLR4) and activate the myeloid differentiation pri-
mary response 88 (Myd88)-dependent branch of the TLR4 pathway24,25. We looked at the expression of two 
intermediates of this pathway. TLR4 and MyD88 mRNA expression were also highly up-regulated in TNC KO 
lungs (Fig. 8f).
Discussion
Based on the previously described critical role of TNC in lung development, we hereby explored how 
TNC-deficiency affected lung function in newborn mice and whether this had repercussions persisting in adult-
hood. The aim of this study was thus to evaluate homozygous TNC KO versus WT mice at two different time 
points: newborn (P5) and adult age (P90 (3 months)). Animals were tested for their lung function under basal 
conditions and after a mechanical stress challenge in order to highlight functional alterations that may otherwise 
be silent.
Figure 3. Lung function in newborn and adult TNC KO and WT mice under basal conditions. Respiratory 
function parameters were collected using a flexiVent system under basal conditions in newborn (P5, Panel a-e) 
and in adult (P90, Panel f-j) WT (■) and TNC-deficient (□) mice. Panel a,f: static compliance (Cst), describing 
the distensibility of the respiratory system. Panel b,g: parameter A, estimate of inspiratory capacity. Panel c,h: 
parameter K, describing the curvature of the PV deflation curve. Panel d,i: hysteresis, estimating atelectasis 
existing before the PV loop (area between the PV inflation and deflation limbs). Panel e,j: representative PV 
loops at time 0. P5: N = 4–7 animals/genotype; P90: N = 6 animals/genotype (Cst done on 8–12 animals/
genotype). Results are expressed as mean ± SD. Statistical analyses were made by two-way ANOVA; statistical 
significance was set at p < 0.05; *p < 0.05, **p < 0.01, ***p < 0.001.
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It is well known that different domains compose TNC protein and control its interaction with numerous 
binding partners4,26. Mouse TNC gene possesses 8 constant and 6 alternatively spliced fnIII domains, each cor-
responding to an exon2,6. Our results confirmed that whereas mRNAs of short and long isoforms of TNC were 
found in newborn lungs, only short isoforms were detected in adult lungs. This is in agreement with the collec-
tion of studies made in different species and recently published as a review6. Short TNC isoforms promote cell 
attachment, cell differentiation and the formation of focal adhesions, whereas long TNC isoforms promote cell 
migration and are expressed when morphogenesis is very active, like in embryogenesis or cancer growth6,8. At 
the protein level, we also confirmed that TNC was highly expressed in the parenchyma but not in the conducting 
airways in newborn WT lung. However, in adult lungs, TNC protein was undetectable, in accordance with pre-
viously published reports27.
Functional evaluation of the newborn TNC KO and WT mice showed that static compliance and inspir-
atory capacity were elevated in the TNC KO animals under basal conditions, indicating a higher respiratory 
system distensibility than their WT counterpart. This difference persisted during one hour of mechanical stress. 
Interestingly, no alteration was observed in the general lung morphology of TNC KO animals relative to WT. 
As assessed, static compliance reflects the intrinsic elastic properties of the respiratory system including sur-
face tension. Two ECM proteins are mainly responsible for elastic properties of the lung: elastin and collagen. 
Collagen represents 50% of lung ECM and is principally composed of fibrillar collagen (collagen I and III). Elastin 
represents 18% of lung ECM and is made essentially of crosslinked elastin surrounded by fibrillin microfibrils28. 
No difference in elastin or collagen staining was observed between TNC KO and WT newborn lungs. Surface 
tension depends on the size of airspaces and the amount and distribution of surfactant. We did not detect any 
morphological difference between TNC KO and WT lungs in hematoxylin-eosin staining, but morphometric 
measurements done by Mund and Schittny in TNC KO lungs showed the existence of a larger lung volume at 
P2–21, accompanied by a smaller length of the free septal edge (length of alveolar entrance rings), a reduced for-
mation (anlage) of new alveolar septa, and a reduced alveolar surface area at P7 (as compared to WT); this result 
Figure 4. Lung function in newborn and adult TNC KO and WT mice during HTV ventilation. Respiratory 
function parameters were collected using a flexiVent system during one hour of HTV ventilation in newborn 
(P5, Panel a-e) and in adult (P90, Panel f-j) WT (■) and TNC-deficient (□) mice. Panel a,f: static compliance 
(Cst), describing the distensibility of the respiratory system. Panel b,g: parameter A, estimate of inspiratory 
capacity. Panel c,h: parameter K, describing the curvature of the PV deflation curve. Panel d,i: hysteresis, 
estimating atelectasis existing before the PV loop (area between the PV inflation and deflation limbs). Panel 
e,j: representative PV loops at time 60. P5: N = 4–7 animals/genotype; P90: N = 6 animals/genotype. Results 
are expressed as mean ± SD. Statistical analyses were made by two-way ANOVA; statistical significance was 
set at p < 0.05; *p < 0.05, **p < 0.01, ****p < 0.0001. Panel k-m: representative results of SP-B and SP-C 
protein detection in whole lung lysates from adult TNC KO and WT animals by Western blots; quantification 
is shown in histogram; N = 5 animals/genotype. Cropped blots are displayed. Full length blots are presented in 
Supplementary Figure S2.
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Figure 5. Lung histology in newborn TNC KO and WT mice. Representative images from lung sections of 
TNC KO and WT P5 animals, either non-ventilated (control) or, for hematoxylin-eosin staining only, ventilated 
during one hour with HTV ventilation. Five µm lung sections were stained with the following staining: Panel 
a-d: hematoxylin-eosin staining for morphological studies; Panel e,f: resorcin-fuchsin staining for elastin (dark 
purple); Panel g,h: Masson Trichrome staining for collagen (green). N = 4–7 animals/genotype. Magnification: 
20x for Panel a-f and 40x for Panel g,h.
Figure 6. Lung histology in adult TNC KO and WT mice. Representative images from lung sections of 
TNC KO and WT P90 animals. Five µm lung sections were stained with the following staining: Panel a,b: 
hematoxylin-eosin staining for morphological studies; Panel c,d: resorcin-fuchsin staining for elastin (dark 
purple); Panel e-h: Masson Trichrome staining for collagen (green). N = 6 animals/genotype. Magnification: 
20x for a-f, and 40x for g,h. Panel i: quantification of collagen area on Masson trichrome staining (40×) using 
ImageJ; results are expressed as collagen area per length of basement membrane; N = 6 animals/genotype. Panel 
j,k: representative results of elastin protein detection in whole lung lysates from adult TNC KO and WT animals 
by Western blots; quantification is shown in histogram; N = 5 animals/genotype. Cropped blots are displayed. 
Full length blots are presented in Supplementary Figure S2.
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was indicative of a delay in classical alveolarization, which was further shown to be caught up during continued 
alveolarization23. Regarding surfactant, no implication of TNC in surfactant metabolism has been shown so far 
and surfactant protein C (SP-C) immunostaining did not reveal any difference between TNC KO and WT lung 
sections (data not shown).
Alpha-SMA is a marker of airway smooth muscle (ASM) cells, vascular smooth muscle cells and myofibro-
blasts in the lung. ASM is the contractile element responsible for bronchoconstriction, airway luminal diameter 
and airway resistance. ASM also produces ECM proteins, pro- and anti-inflammatory mediators and growth 
factors necessary to influence the proliferation, migration and apoptosis of other resident cells like epithelial 
cells, fibroblasts, or ASM cells themselves29–31. In newborn TNC KO mice, we observed a weaker α-SMA stain-
ing around small airways and at the tips of the developing septa, and to a lesser extent around large airways and 
blood vessels. It is not clear whether ASM cell layer is thinner or α-SMA is less expressed in ASM cells in TNC 
KO animals. However, this could potentially be associated with a more heterogeneous ventilation in the TNC 
KO mice as a result of more easily collapsible small airways. This might also provide an explanation to the fact 
that compliance remained elevated in the newborn mice following the mechanical stress challenge as the weaker 
α-SMA staining found at the tips of the free septa (most probably myofibroblasts), representing a reduced α-SMA 
content in the alveolar entrance rings, would also be expected to result in a decreased tissue resistance and more 
Figure 7. α-SMA protein expression in lungs of adult TNC KO and WT mice. Panel a-f: representative 
images from lung sections of WT (a,c,d) and TNC KO (b,e,f) P5 (a,b) and P90 (c–f) animals immunostained 
with anti-α-SMA antibody (dark grey), and counter-stained with Nuclear Red. Magnification: 20x for c,e and 
40x for a,b,d,f. N = 4–7 animals/genotype for newborns and N = 6 animals/genotype for adults. Panel g-j: 
representative results of α-SMA protein detection in whole lung lysates from newborn (g,i) and adult (h,j) TNC 
KO and WT animals by Western blots; quantification is shown in histogram; N = 3–4 animals/genotype for 
newborns and N = 5 animals/genotype for adults. Cropped blots are displayed. Full length blots are presented in 
Supplementary Figure S2. Panel k,m: representative results of phosphorylated form of smooth muscle myosin 
light chain (PMLC2) protein detection in whole lung lysates from adult TNC KO and WT animals by Western 
blots; quantification is shown in histogram; N = 5 animals/genotype. Cropped blots are displayed. Full length 
blots are presented in Supplementary Figure S2. Panel l,n: representative results of smooth muscle myosin 
heavy chain (MYH11) protein detection in whole lung lysates from adult TNC KO and WT animals by Western 
blots; quantification is shown in histogram; N = 5 animals/genotype. Cropped blots are displayed. Full length 
blots are presented in Supplementary Figure S2. Results are expressed as mean ± SD. Panel o-s: flow cytometry 
experiment done on adult TNC KO and WT lung samples using α-SMA, desmin and vimentin antibodies. Ki67 
was used to measure proliferation. N = 3 animals/genotype. Statistical analyses were made by Student t test; 
statistical significance was set at p < 0.05; **p < 0.01.
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airway instability during HTV. Overall, the differences in morphometric measurements showing an emphysema-
tous profile of TNC KO lungs compared to WT lungs23, and the reduced branching observed in TNC KO lungs 
explants during early lung development22 could explain the increased static compliance and inspiratory capacity 
observed in newborn TNC-deficient mice.
Adult TNC KO mice, like the newborn ones, also displayed under basal conditions a higher static compliance 
and inspiratory capacity than their age-matched WT controls, indicating a persistent functional impairment 
following TNC inactivation. However, under HTV ventilation, both genotypes behaved in a similar manner sug-
gesting that despite its underlying functional impairment, the adult TNC KO lungs were able to cope during the 
mechanical stress challenge. Adult mice have been previously shown to be more susceptible to HTV mechanical 
ventilation than newborn mice32. Therefore, when newborn mice were ventilated with a tidal volume of 40 ml/kg, 
adult mice were ventilated with 25 ml/kg for a similar challenge. No striking differences in lung morphology or 
elastin staining/protein expression were either observed between adult TNC KO and WT mice. Morphometric 
measurements done previously by Mund and Schittny also showed a similar lung volume, length of the free septal 
edge, formation (anlage) of new septa and alveolar surface area in both genotypes at 3 months of age (P86)23. No 
difference in SP-C immunostaining was either observed in TNC KO versus WT lung sections (data not shown), 
but a slight increase in SP-C, but not SP-B, protein expression, speaking for an enhanced efficacy of surfactant, 
was observed in whole lung lysates from adult TNC KO mice relative to WT. On the other hand, there was clearly 
a weaker α-SMA immunostaining around small airways and to a lesser extend around large airways and blood 
vessels as in the newborn mice and, interestingly, collagen staining revealed a thickened subepithelial collagen 
layer around small airways in TNC KO lungs. These differences in collagen and surfactant might have protected 
the adult TNC KO lungs during HTV, which is susceptible to induce lung injury as a result of repetitive overd-
istention and derecruitment. These differences might therefore explain the observed unchanged static compliance 
in TNC-deficient mice at P90 relative to WT and the lack of a similar effect at P5. Finally, the slight increase in 
SP-C could also have contributed in the increase in static compliance and inspiratory capacity seen under basal 
conditions in the adult TNC KO mice.
In adult lungs, flow cytometry experiments confirmed the large decrease in SMA + cells observed in TNC 
KO lungs by immunohistochemistry. Both smooth muscle cells (SMC) and myofibroblasts cell numbers were 
Figure 8. TGFβ and TLR4 pathway intermediates are upregulated in adult TNC KO lungs. Panel a: mRNA 
expression of TGFβ pathway intermediates evaluated by RT-qPCR in whole lung lobe homogenates of adult 
TNC KO and WT mice. N = 3–4 animals/genotype. Panel b-e: Representative results of phosphorylated smad2 
and smad3 protein detection in whole lung lysates from adult TNC KO and WT mice; 20 or 160ug of whole 
lung lobe lysates were loaded on 7.5% SDS-Page gels. N = 5 animals/genotype. Cropped blots are displayed. 
Full length blots are presented in Supplementary Figure S2. Panel f: mRNA expression of TLR4 pathway 
intermediates evaluated by RT-qPCR in whole lung lobe homogenates of TNC KO and WT adult mice. N = 3–4 
animals/genotype. Results are expressed as mean ± SD. Statistical analyses were made by Student t test; 
statistical significance was set at p < 0.05; *p < 0.05, **p < 0.01.
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decreased. Moreover, the proliferating fractions of these two populations were also lower in TNC KO compared 
to WT lungs, pointing to a general decrease in SMA + cells proliferation in the absence of TNC. SMA + cells 
originate from mesenchymal cells during branching morphogenesis (peribronchiolar stage) for smooth muscle 
cells, and during alveolar stage for myofibroblasts. During branching morphogenesis, pluripotent mesenchymal 
cells present at the distal end of each growing branch migrate in a distal to proximal direction along the branches. 
Under the combined action of factors from mesodermal and epithelial origin acting in a cooperative way, they give 
rise to pools of SMC progenitors and then differentiated SMCs. These factors are principally: fibroblast growth 
factor 10/9 (FGF10/9), Wnts, sonic hedgehog (Shh), bone morphogenetic protein 4 (Bmp4), platelet-derived 
growth factor receptor (PDGFR), but also vascular endothelial growth factor (VEGF) or TGFβ33,34. Wnt secreted 
by the adjacent developing epithelium is necessary for expansion and differentiation of SMC progenitors, and it 
was shown to act through a Wnt/TNC/PDGFR pathway35. This could indicate that absence of TNC impairs SMC 
progenitors pool formation, and therefore, explains the lower number of SMA + cells in TNC KO adult lungs.
At the molecular level though, whole lung α-SMA, but also myosin heavy and light (phosphorylated form) 
chain protein expression was either slightly upregulated or unchanged in adult TNC KO lungs. It is possible 
that the discrepancy between α-SMA immunohistochemistry/flow cytometry and Western blot results comes 
from the monomer versus polymer status of α-SMA protein. Indeed, actin monomers polymerize in actin fila-
ments (with troponin and tropomyosin), and complexes with myosin filaments to form smooth muscle fibers. 
Alpha-SMA monomers could be detected by Western blot (denaturing gels), but not be uncovered by immunohis-
tochemistry or flow cytometry. Or it could simply be that each SMA + cell expresses higher levels of SMA in TNC 
KO than in WT lungs. SMA gene expression is under the control of many factors among which TNC, through 
the TLR4/Myd88 pathway. Indeed, TNC was shown to induce the synthesis of inflammatory markers through the 
Myeloid differentiation primary response 88 (MyD88)-dependent signaling pathway of TLR424,25. But TNC also 
induces α-SMA, collagen I and TGFβ expression, as well as myofibroblast differentiation/recruitment, through 
TLR4 receptor, while in return, TGFβ induces TNC through the TGFβ pathway13,36–44. In our experiments, TGFβ 
pathway intermediates were not down-regulated in TNC KO lungs, but rather up-regulated, maybe as a compen-
satory mechanism. mRNA expression of TGFβ1 and of all three TGFβ receptors were increased, while TGFb2 
and −3 mRNA expression were unchanged. This is in accordance with the fact that TGFβ1 is expressed both 
during embryogenesis and adulthood, whereas TGFβ2 and −3 are abundantly expressed essentially in develop-
ing organs45. TLR4 pathway members Myd88 and TLR4 were up-regulated as well in TNC KO lungs. This could 
contribute to the increase in SMA gene and protein expression. Interestingly, TNC was shown to bind TLR4 via 
its C-terminal fibrinogen-like globe (FBG) domain. Yet, TNC is not the only protein bearing an FBG domain. 
Tenascins belong to the fibrinogen-related proteins (FREPs) family that all bear an FBG domain. If not all FBG 
domains are able to activate TLR4, Zuliani-Alvarez et al. showed that the presence of a cationic ridge in the FBG 
domain defined the capacity to activate TLR446.
Increased TNC expression was reported in lungs of patients with asthma and chronic lung inflammation10,47,48. 
Increased TNC expression was also found in lungs of COPD patients, where an obstructive component also 
occurs in form of chronic bronchitis15. In animal experiments, Nakahara et al. showed that TNC inactivation was 
protective against ovalbumin-induced asthma, with less eosinophils in the bronchoalveolar lavage fluid (BALF), 
decreased lung cell infiltration and reduced Th2 cytokines IL-5 and IL-13 in BALF and plasma21. Doan et al. 
further showed that TNC KO lungs exhibited a decreased expansion while accelerated maturation of eosinophil 
progenitors in the same asthma model49. In a model of bleomycin-induced acute lung injury (ALI), Carey et al. 
showed that TNC KO lungs were protected from fibrosis, with less SMA + myofibroblasts in the lung, and TNC 
inactivation prevented constitutively active TGFβ to induce the differentiation of fibroblasts into myofibroblasts19. 
ASM hypertrophy is largely implicated in diseases like asthma, but also bronchitis and COPD, where thickening 
of ASM and airway remodeling lead to a decrease in bronchial diameter or airway obstruction50,51. The effect of 
down-regulation of α-SMA + cells following TNC inactivation could therefore constitute an interesting approach 
in the prevention or treatment of obstructive pulmonary diseases with thickened ASM layer or heterogeneous 
ventilation. Indeed, the same Wnt/TNC/PDGFR pathway regulating SMC formation and differentiation during 
lung development was recently shown to recur in airway remodeling in chronic asthma52,53.
Altogether, the results hereby presented demonstrate that TNC deficiency induces defects in lung develop-
mental processes having functional implications that persist in adulthood. TNC being no more expressed at this 
stage, the functional alteration of adult TNC KO mice probably originated from lung development alterations, 
but subsisted in adulthood in part due to persistent architectural/structural modifications (SMA + cells, collagen) 
and impaired gene expression (TGFβ and TLR4 pathways). Silencing of TNC expression might be an interesting 
approach for the prevention of ASM thickening in patients with functional and structural airway obstruction or 
ventilation heterogeneity, like in asthma or COPD.
Methods
Animals. All experiments were approved by the animal ethic commissions of the Federal Food Safety and 
Veterinary Office, and the Veterinary Service of the Canton Bern and performed in accordance with the Swiss 
Federal Act in Animal protection guidelines and regulations. TNC KO mice18 were bred on a 129SV background. 
Postnatal day 5 (P5) and 3 months old (P90) TNC KO and WT animals were anesthetized with a mixture of 
Midazolam (5 mg/kg BW), Fentanyl (0.05 mg/kg BW) and Medetomidin (0.5 mg/kg BW), and then intratrache-
ally intubated and connected to a computer-controlled piston ventilator (flexiVent, SCIREQ Scientific Respiratory 
Equipment Inc., Montreal, Canada) for mechanical ventilation and for the construction of pressure-driven pres-
sure-volume (PV) curves. The animals were first ventilated with a standard mouse ventilation profile (respiratory 
rate: 150/min; tidal volume: 10 ml/kg; PEEP: 3cmH2O) and PV curves were constructed in a step-wise manner 
under closed-chest conditions (basal conditions). Then, mechanical ventilation was switched to a high amplitude 
ventilation mode (HTV) and the subjects were ventilated for 1 h with room air at a respiratory rate of 60/min, an 
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increased tidal volume (25 ml/kg for the adults and 40 ml/kg for the newborns) and a PEEP of 0cmH2O. During 
that time, PV curves were recorded every 15 minutes, while the animals were kept on a heating pad with rectal 
temperature being maintained at 35–37 °C and heart rate monitored by ECG. The Salazar-Knowles equation54 
was fitted to the pressure and volume signals at each plateau of the deflation limb of the PV curves directly in 
the flexiVent operating system (flexiWare version 7.2) and the following parameters were automatically obtained 
after each measurement: Static compliance (Cst): describing the distensibility of the respiratory system (lungs and 
chest walls) at 5 cmH2O, parameter A: an estimate of the inspiratory capacity and parameter K: the exponential 
function capturing the curvature of the PV curves. In addition, the area between the inflation and deflation limbs 
of the PV curve (hysteresis) was calculated, as well as the work-of-breathing (WOB) from the area under the 
inflation limb, normalized to the maximal volume.
At the end of an experiment, the animal was sacrificed with an overdose of the anesthetic mixture. The left 
lung lobe was ligated and snap-frozen for RNA/protein extraction. The right lobes were inflated with freshly 
prepared paraformaldehyde 4% at a pressure of 20 cmH2O, fixed and stored for histological analyses. Pressure 
was maintained during fixation for at least 2 hours at 4 °C, to prevent the lung from recoiling. Non-ventilated 
age-matched animals were used as controls.
Rt-qpcR. Frozen lungs were ground to powder using pre-cooled mortar and pestle, and re-suspended in 
RNAzol (Sigma-Aldrich, Darmstadt, Germany). Total RNA was extracted following the manufacturer’s protocol. 
Reverse transcription was realized using PrimeScript 1st strand cDNA synthesis kit (Takara Bio Inc., Kusatsu, 
Shiga, Japan). qPCR was performed using a Corbett Rotor-Gene 6000 apparatus and Rotor-Gene SYBR Green 
PCR kit (QIAGEN, Hilden, Germany). Primers were: 5s-6as and 5f-6r55. Program was: 45 cycles of 20 sec at 95 °C, 
30 sec at 57 °C for 5s-6as/59 °C for 5f-6r and 60 sec at 72 °C. qPCR samples were run on 2% agarose gels contain-
ing GelRed Nucleic Acid Gel Stain (Biotium Inc., Fremont, CA, USA) and visualized on a UV table. For mRNA 
expression analyses, primers used are shown in Supplementary Table SI. Program was a standard 2-steps program 
with 40 cycles of 5 sec denaturation at 95 °C and 10 sec annealing/amplification at 60 °C.
Histology. Lungs were fixed in freshly prepared 4% paraformaldehyde at 4 °C for 2 h. Fixed lungs were then 
embedded in paraffin and 5 µm sections were cut using a MicroM microtome (Thermo Fischer Scientific Inc., 
Reinach, Switzerland). Hematoxylin-eosin (1 min in hematoxylin, 5 min in running tap water, 20 dips in ascend-
ing EtOH solutions from 70 to 100%, 20 sec in eosin), resorcin-fuchsin (30 min in Weigert’s resorcin-fuchsin solu-
tion, 20 dips in running tap water, 10 sec in acid alcohol, 2 min in tap water, 20 dips in distilled water) and Masson 
trichrome (1 min in hematoxylin, 5 min in running tap water, 10 min in fuchsin-ponceau solution (1% fuchsin, 
1% Ponceau in 1% acetic acid), 20 dips in distilled water, 3 min in 1% phosphomolybdic acid, 1 min in fast green 
FCF (in 1% acetic acid), rinsing in 1% acetic acid) stainings were used to evaluate basic morphology, elastin and 
collagen distribution, respectively. Three pictures of two different lung sections of each animal were evaluated by 
three different examiners (SG, TPC and JCS) for each staining. Criteria for the evaluation of differences between 
genotypes were to be able to sort the pictures by genotype, not knowing to which animal it belonged. For Masson 
trichrome staining, a quantitative analysis of collagen was performed by a single examiner (SG) using the free 
ImageJ software (Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, https://
imagej.nih.gov/ij/, 1997–2018). For each high magnification image (40×), a color threshold was applied to iden-
tify the stained structure. The results are reported as the collagen area per length of basement membrane.
immunohistochemistry. Five µm sections were deparaffinized, treated with 0.3% H2O2 to block endog-
enous peroxidases, and rehydrated. Depending on the protein targeted, sections were treated 20 min in 0.01 M 
sodium citrate pH6 at 95 °C for heat-induced antigen retrieval, before being blocked with pre-immune serum 
and incubated with primary antibodies for 1–4 hours. Secondary antibody system was composed of biotinylated 
secondary antibody, Vectastain ABC HRP kit (PK-4000) and Vector SG HRP substrate kit (SK-4700) (Vector 
Laboratories, Burlingame, CA, USA). Counter-staining was done with Nuclear Fast Red (#6070-5 G) (Fluka, 
Buchs, Switzerland). Primary antibodies were: anti-α-SMA (A2547) (Sigma-Aldrich, Darmstadt, Germany), 
anti-tenascin C (LS-C313183) (LifeSpan BioSciences Inc., Seattle, WA, USA). For α-SMA antibody, the Mouse 
on Mouse Detection Kit was used (BMK-2202) (Vector Laboratories, Burlingame, CA, USA). Pictures of three 
different experiments were evaluated by three different examiners (SG, TPC and JCS) for each immunohisto-
chemical staining. Criteria for the evaluation of differences between genotypes were to be able to sort the pictures 
by genotype, not knowing to which animal it belonged.
Western blot. Frozen lung lobes were ground to powder using pre-cooled mortar and pestle, and resus-
pended in RIPA buffer (Pierce #89900, Thermo Fisher Scientific Inc., Waltham, MA, USA) plus anti-proteases 
and anti-phosphatases. Protein lysates were quantified by BCA protein assay (Pierce #23225, Thermo Fisher 
Scientific Inc., Waltham, MA, USA). Twenty ug (except Psmad2: 160 ug) were loaded on 7.5% SDS-PAGE gels and 
transferred to nitrocellulose membranes. After blocking with casein 1x solution (#SP-5020 Vector Laboratories, 
Burlingame, CA, USA) or 5% BSA fraction V (#A1391,0100; Applichem GmbH, Darmstadt, Germany) in TBS 
1X (50 mM Tris-HCl, pH 7.5; 150 mM NaCl) for phospho-proteins, membranes were incubated overnight 
with the following primary antibodies: anti-α-SMA (#A2547) (1:250) and anti-α-actinin (#A5044) (1:250) 
(Sigma-Aldrich Inc., Saint-Louis, MI, USA), anti-Psmad2 (#3108 S) (1:1’000) and anti-phospho-myosin light 
chain 2 (#3674) (1:1’000) (Cell Signaling Technology, Danvers, MA, USA), anti-Psmad3 (#ab51177) (1:2’000), 
anti-elastin (#ab21610) (1:200) and anti-tenascin-C (#AB108930) (1:1’000) (Abcam, Cambridge, UK), anti-SP-C 
(#sc-13979) (1:100) (Santa Cruz Biotechnology Inc., Dallas, TX, USA), anti-SP-B (#NBP1-57977) (1:500) (Novus 
Biologicals, Centennial, CO, USA) and anti-myosin heavy chain 11 (#GTX131414) (1:500) (Genetex Inc., 
Irvine, CA, USA). They were subsequently incubated with the following secondary antibodies during one hour: 
1 1Scientific RepoRtS |         (2020) 10:5118  | https://doi.org/10.1038/s41598-020-61919-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
anti-mouse (926–32212) (IRDye 800CW Donkey Anti-Mouse IgG (H + L)) or anti-rabbit (926–68073) (IRDye 
680RD Donkey (polyclonal) Anti-Rabbit IgG (H + L), LI-COR Biosciences Inc., Lincoln, NE, USA) secondary 
antibodies. Signal was revealed with a LI-COR Odyssey Infrared Imaging System (LI-COR Biosciences Inc., 
Lincoln, NE, USA), analyzed and quantified using the free ImageJ software.
flow cytometry. Lungs were chopped to tiny pieces with scalpels and scissors. They were then treated with 
10 mL of 0.1% Collagenase I and 0.25% Collagenase II (Worthington Biochemical Corporation, Lakewood, NJ, 
USA) in 4% FBS 1X PBS for 2 h at 37 °C / 5%CO2. Fully supplemented RPMI-1640 was added to deactivate the 
collagenase solution and cell suspensions were passed through cell strainers of 100 and then 40μm (SPL Life 
Sciences, Cat. No.: 93100 and 93040) in order to obtain single cell suspensions. Cells were also treated with 
red blood lysis buffer for 10 min at 4 °C to remove red blood cells. This method is described in56. Cells were 
then washed with PBS, and fixed and permeabilized with the BD Cytofix/CytopermTM kit (Cat. No.: 554714 
BD Biosciences). Ki67 marker was used to measure proliferation (#ab15580) (Abcam, Cambridge, UK). Cells 
were stained for α-SMA (#NBP2-34760PE) (1:200) (Novus Biologicals LLC, Centennial, CO, USA), desmin 
(#ab32362) (1:70) (Abcam, Cambridge, UK) and vimentin (#ab194719) (1:5’000) (Abcam, Cambridge, UK). 
Secondary antibodies were Goat anti-Rabbit (#P-10994) (1:100) (Thermo Fischer Scientific Inc., Reinach, 
Switzerland) (secondary antibody to desmin) and Goat anti-Rabbit (#ab150077) (1:2’000) (Abcam, Cambridge, 
UK) (secondary antibody to Ki67). Since both secondary antibodies were Goat anti-Rabbit, first cells were stained 
with Ki67 and Goat anti-Rabbit-Alexa 488. Then cells were washed and staining with α-SMA, vimentin and 
desmin followed. Finally, cells were washed and stained for goat anti-Rabbit-Pacific Blue. Cells were washed and 
flow cytometry analysis followed. Myofibroblasts were characterized as α-SMA+/vimentin+/desmin−. Cells that 
were α-SMA+/vimentin−/desmin+ were characterized as α-SMA cells. The entire staining procedure was done 
on ice. Single cell gate was set as the stopping gate and at least 30,000 events were acquired per sample. Data was 
analyzed on FlowJo software (Tri-Star). A representative gating strategy is shown on Supplementary Figure S1.
Statistical analyses. Statistical analyses were done in GraphPad Prism software (GraphPad software Inc., La 
Jolla, CA, USA). Either two-way ANOVA (for respiratory function parameters and flow cytometry experiments) 
or Student’s t test for two by two comparisons (for Western blots and RT-qPCR experiments) were used.
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All data generated or analyzed during this study are included in this published article.
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